Access cutting-edge prostatic neoplasms, castration-resistant treatment through this clinical trial at a research site in East Hanover. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this East Hanover location
Preparing your pre-screening questions…
Access prostatic neoplasms, castration-resistant specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostatic neoplasms, castration-resistant treatment provided free
Check if you qualify for this prostatic neoplasms, castration-resistant clinical trial in East Hanover, NJ
No-Cost Study Care
Local to East Hanover
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The aim of this study is to assess treatment patterns, clinical outcomes, and patient characteristics among adults with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US) real-world clinical practice. This study will be conducted using data extracted from the PRECISION (PRostatE Cancer dISease observatION) data platform.
Sponsor: Novartis Pharmaceuticals
Yes, this clinical trial (NCT07677254) has an active research site in East Hanover, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for prostatic neoplasms, castration-resistant treatment options in East Hanover, NJ, this clinical trial (NCT07677254) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our East Hanover research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostatic neoplasms, castration-resistant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all prostatic neoplasms, castration-resistant clinical trials near you to find additional studies recruiting in your area.
See all multiple sclerosis clinical trials recruiting in East Hanover — not just this study.
Browse Multiple Sclerosis Trials in East Hanover →